Weight Management References 29677

Nov. 7, 2005 - Natural Products INSIDER
"Weight Management" References

1 Vasan RS et al. "Estimated risks for developing obesity in theFramingham Heart Study." Ann Intern Med. 143, 7:473-80, 2005. www.annals.org

2. Finkelstein EA, Fiebelkorn IC, Wang G. "State-level estimates ofannual medical expenditures attributable to obesity." Obes Res. 12,1:18-24, 2004. www.obesityresearch.org.

3. Kruger J et al. "Attempting to lose weight: specific practices amongU.S. adults." Am J Prev Med. 26, 5:402-6, 2004. www.sciencedirect.com/science/journal/07493797

4. Westerterp-Plantenga MS, Lejeune MP. "Protein intake and body-weightregulation." Appetite. 45, 2:187-90, 2005.

5. Schoeller DA, Buchholz AC. "Energetics of obesity and weight control:does diet composition matter?" J Am Diet Assoc. 105, 5 Suppl1:S24-8, 2005. www.eatright.org/journal

6. Weigle DS et al. "A high-protein diet induces sustained reductions inappetite, ad libitum caloric intake and body weight despite compensatory changesin diurnal plasma leptin and ghrelin concentrations." Am J Clin Nutr.82, 1:41-8, 2005. www.ajcn.org

7. Nickols-Richardson SM et al. "Perceived hunger is lower and weightloss is greater in overweight premenopausal women consuming alow-carbohydrate/high-protein vs high-carbohydrate/low-fat diet." J AmDiet Assoc. 105, 9:1433-7, 2005. www.eatright.org/journal

8. Due A et al. "Effect of normal-fat diets, either medium or high inprotein, on body weight in overweight subjects: a randomized 1-year trial."Int J Obes Relat Metab. 28, 10:1283-90, 2004.

9. Zemel MB et al. "Calcium and dairy acceleration of weight and fatloss during energy restriction in obese adults." Obes Res. 12,4:582-90, 2004. www.obesityresearch.org.

10. Zemel MB et al. "Dairy augmentation of total and central fat loss inobese subjects." Int J Obes (Lond). 29, 4:391-7, 2005.

11. Schrager S. "Dietary calcium intake and obesity." J Am BoardFam Pract. 18, 3:205-10, 2005. www.jabfp.org

12. Loos RJ et al. "Calcium intake is associated with adiposity in blackand white men and white women of the HERITAGE Family Study." J Nutr.134, 7:1772-8, 2004. www.nutrition.org

13. Riedt CS et al. "Overweight postmenopausal women lose bone withmoderate weight reduction and 1 g/day calcium intake." J Bone Miner Res.20, 3:455-63, 2005. www.jbmr-online.com

14. Anderson JW, Hoie LH. "Weight loss and lipid changes with low-energydiets: comparator study of milk-based versus soy-based liquid meal replacementinterventions." J Am Coll Nutr. 24, 3:210-6, 2005. www.jacn.org

15. Allison DB et al. "A novel soy-based meal replacement formula forweight loss among obese individuals: a randomized controlled clinicaltrial." Eur J Clin Nutr. 57, 4:514-22, 2003. www.naturesj.com/ejcn

16. Deibert P et al. "Weight loss without losing muscle mass inpre-obese and obese subjects induced by a high-soy-protein diet." Int JObes Relat Metab Disord. 28, 10:1349-52, 2004. http://www-us.ebsco.com/online/OnlineTitles.asp

17. Slavin JL. "Dietary fiber and body weight." Nutrition.21, 3:411-8, 2005.

18. Marlett JA, McBurney ML, Slavin JL. "Position of the AmericanDietetic Association: health implications of dietary fiber." J Am DietAssoc. 102, 7:993-1000, 2002. www.eatright.org/journal

19. Gonzalez Canga A et al. "[Glucomannan: properties and therapeuticapplications.]" Nutr Hosp. 19, 1:45-50, 2004.

20. McCarty MF. "Glucomannan minimizes the postprandial insulin surge: apotential adjuvant for hepatothermic therapy." Med Hypotheses. 58,6:487-90, 2002. www.harcourt-international.com/journals/mehy

21. Birketvedt GS et al. "Experiences with three different fibersupplements in weight reduction." Med Sci Monit. 11, 1:PI5-8, 2005. www.medscimonit.com

22. Jena BS et al. "Chemistry and biochemistry of (-)-hydroxycitric acidfrom Garcinia." J Agric Food Chem. 50, 1:10-22, 2002. http://pubs.acs.org/journals/jafcau

23. Ohia SE et al. "Safety and mechanism of appetite suppression by anovel hydroxycitric acid extract (HCA-SX). Mol Cell Biochem. 238,1-2:89-103, 2002. www.wkap.nl

24. Roy S et al. "Body weight and abdominal fat gene expression profilein response to a novel hydroxycitric acid-based dietary supplement." GeneExp. 11:251-62, 2004.

25. Monjok EM et al. "Regulation of rat brain Neuropeptide Yconcentration by hydroxycitric acid, in vitro." Presented at ExperimentalBiology 2005, San Diego, April 2, 2005.

26. Tomita K et al. "(-)-hydroxycitrate ingestion increases fatoxidation during moderate intensity exercise in untrained men." BiosciBiotechnol Biochem. 67, 9:1999-2001, 2003. www.jstage.jst.go.jp

27. Lim K et al. "(-)-hydroxycitric acid ingestion increases fatutilization during exercise in untrained women." J Nutr Sci Vitaminol(Tokyo). 49, 3:163-7, 2003.

28. Lim K et al. "Short-term (-)-hydroxycitrate ingestion increases fatoxidation during exercise in athletes." J Nutr Sci Vitaminol (Tokyo).48, 2:128-33, 2002.

29. Downs BW et al. "Bioefficacy of a novel calcium-potassium salt of(-)-hydroxycitric acid." Mutat Res. July 27, 2005. [epub ahead ofprint] www.mutationresearch.com

30. Soni MG et al. "Safety assessment of (-)-hydroxycitric acid andSuper CitriMax, a novel calcium/potassium salt." Food Chem Tox. 42,9:1513-29, 2004. www.elsevier.nl/locate/foodchemtox

31. MacLean DB, Luo LG. "Increased ATP content/production in thehypothalamus may be a signal for energy-sensing of satiety: studies of theanorectic mechanism of a plant steroidal glycoside." Brain Res.1020, 1-2:1-11, 2004. www.elsevier.nl/inca/publications/store/5/0/6/0/4/8/

32. Burns AA et al. "Short-term effects of yoghurt containing a novelfat emulsion on energy and macronutrient intakes in non-obese subjects." IntJ Obes Relat Metab Disord. 24, 11:1419-25, 2000. http://www-us.ebsco.com/online/OnlineTitles.asp

33. Burns AA et al. "The effects of yoghurt containing a novel fatemulsion on energy and macronutrient intakes in non-overweight, overweight andobese subjects." Int J Obes Relat Metab Disord. 25, 10:1487-96,2001. http://www-us.ebsco.com/online/OnlineTitles.asp

34. Burns AA et al. "Dose-response effects of a novel fat emulsion(Olibra) on energy and macronutrient intakes up to 36 h post-consumption." EurJ Clin Nutr. 56, 4:368-77, 2002. www.naturesj.com/ejcn

35. Preuss HG et al. "Citrus aurantium as a thermogenic,weight-reduction replacement for ephedra: an overview." J Med. 33,1-4:247-64, 2002. www.medical-library.org/j_med.htm

36. Allison DB et al. "Exactly which synephrine alkaloids does Citrusaurantium (bitter orange) contain?" Int J Obes (Lond). 29, 4:443-6,2005.

37. Colker CM et al. "Effects of Citrus aurantium extract, caffeine andSt. John's wort on body fat loss, lipid levels and mood states in overweighthealthy adults." Curr Ther Res. 60, 3:145-53, 1999. www.currenttherapeuticres.com

38. Gougeon R et al. "Increase in the thermic effect of food in women byadrenergic amines extracted from citrus aurantium." Obes Res. 13,7:1187-94, 2005. www.obesityresearch.org.

39. Haller CA, Benowitz NL, Jacob P 3rd. "Hemodynamic effects ofephedra-free weight-loss supplements in humans." Am J Med. 118,9:998-1003, 2005. www-east.elsevier.com/ajm/menu.html

40. Sayama K et al. "Effects of green tea on growth, food utilizationand lipid metabolism in mice." In Vivo. 14, 4:481-4, 2000. www.iiar-anticancer.org/index2.htm

41. Ashida H et al. "Anti-obesity actions of green tea: possibleinvolvements in modulation of the glucose uptake system and suppression of theadipogenesis-related transcription factors." Biofactors. 22,1-4:135-40, 2004. http://iospress.metapress.com

42. Westererp-Plantenga MS, Lejeune MP, Kovacs EM. "Body weight loss andweight maintenance in relation to habitual caffeine intake and green teasupplementation." Obes Res. 13, 7:1195-204, 2005. www.obesityresearch.org

43. Dulloo AG et al. "Green tea and thermogenesis: interactions betweencatechin-polyphenols, caffeine and sympathetic activity." Int J ObesRelat Metab Disord. 24, 2:252-8, 2000. http://www-us.ebsco.com/online/OnlineTitles.asp

44. Zheng G et al. "Anti-obesity effects of three major components ofgreen tea, catechins, caffeine and theanine, in mice." In Vivo.18:55-62, 2004. www.iiar-anticancer.org/index2.htm

45. Hung PF et al. "Antimitogenic effect of green tea(-)-epigallocatechin gallate on 3T3-L1 preadipocytes depends on the ERK and Cdk2pathways" Am J Physiol Cell Physiol. 288, 5:C1094-108, 2005. http://ajpcell.physiology.org

46. Lin J, Della-Fera MA, Baile CA. "Green tea polyphenolepigallocatechin gallate inhibits adipogenesis and induces apoptosis in 3T3-L1adipocytes." Obes Res. 13, 6:982-90, 2005. www.obesityresearch.org

47. Klaus S et al. "Epigallocatechin gallate attenuates diet-inducedobesity in mice by decreasing energy absorption and increasing fatoxidation." Int J Obes (Lond). 29, 6:615-23, 2005.

48. Wolfram S et al. "TEAVIGO (epigallocatechin gallate) supplementationprevents obesity in rodents by reducing adipose tissue mass." Ann NutrMetab. 49, 1:54-63, 2005. www.karger.com/anm

49. Kalmann DS et al. "A randomized, double blind, placebo-controlledstudy of 3-acetyl-7-oxo-dehydroepiandrosterone in healthy overweightadults." Curr Ther Res. 61, 7:435-42, 2000. www.currenttherapeuticres.com

50. Zenk JL et al. "The effect of 7-Keto Naturalean<\#170> onweight loss: a randomized, double blind, placebo-controlled trial." CurrTher Res. 63, 4:263-72, 2002. www.currenttherapeuticres.com

51. Zenk JL et al. "Effect of lean system 7 on metabolic rate and bodycomposition." Nutrition. 21, 2:179-85, 2005. www.journals.elsevierhealth.com/periodicals/nut

52. Rainer L, Heiss CJ. "Conjugated linoleic acid: health implicationsand effects on body composition." J Am Diet Assoc. 104, 6:963-8,2004. www.eatright.org/journal

53. House RL et al. "Conjugated linoleic acid evokes de-lipidationthrough the regulation of genes controlling lipid metabolism in adipose andliver tissue." Obes Rev. 6, 3:247-58, 2005.

54. Terpstra AH. "Effect of conjugated linoleic acid on body compositionand plasma lipids in humans: an overview of the literature." Am J ClinNutr. 79, 3:352-61, 2004. www.ajcn.org

55. Tricon S et al. "The effects of conjugated linoleic acid on humanhealth-related outcomes." Proc Nutr Soc. 64, 2:171-82, 2005. www.cabi-publishing.org/journals/pns

56. Riserus U, Berglund L, Vessby B. "Conjugated linoleic acid (CLA)reduced abdominal adipose tissue in obese middle-aged men with signs of themetabolic syndrome: a randomized controlled trial." Int J Obesity.25:1129-35, 2001. www.nature.com/ijo

57. Blankson H et al. "Conjugated linoleic acid reduces body fat mass inoverweight and obese humans." J Nutr. 130:2943-8, 2000. www.nutrition.org

58. Gaullier JM et al. "Conjugated linoleic acid supplementation for 1 yreduces body fat mass in healthy overweight humans." Am J Clin Nutr.79:1118-25, 2004. www.ajcn.org

59. Gaullier JM et al. "Supplementation with conjugated linoleic acidfor 24 months is well tolerated by and reduces body fat mass in healthy,overweight humans." J Nutr. 135, 4:778-84, 2005. www.nutrition.org

60. "A patented phytonutrient for weight management by promoting leanbody mass." Company research from Sabinsa Corp., 1999. www.sabinsa.com

61. Krieder R et al. "Effects of Coleus forskohlii extractsupplementation on body composition and markers of health in sedentaryoverweight female." Company research from Sabinsa Corp., 2002. www.sabinsa.com

62. Han LK et al. "Effects of Coleus forskohlii on fat storage inovariectomized rats." Yakugaku Zasshi. 125, 5:449-53, 2005. www.jstage.jst.go.jp

63. Reda E et al. "The carnitine system and body composition." ActaDiabetol. 40 Suppl 1:S106-13,2003.

64. Wutzke KD, Lorenz H. "The effect of L-carnitine on fat oxidation,protein turnover, and body composition in slightly overweight subjects." Metabolism.53, 8:1002-6, 2004. www.sciencedirect.com/science/journal/00260495

65. Muller DM et al. " Effects of oral L-carnitine supplementation on invivo long-chain fatty acid oxidation in healthy adults." Metabolism.51, 11:1389-91, 2002. www.sciencedirect.com/science/journal/00260495

66. Saldanha Aoki M et al. "Carnitine supplementation fails to maximizefat mass loss induced by endurance training in rats." Ann Nutr Metab.48, 2:90-4, 2004. www.karger.com/anm

67. Brandsch C, Eder K. "Effect of L-carnitine on weight loss and bodycomposition of rats fed a hypocaloric diet." Ann Nutr Metab. 46,5:205-10, 2002. www.karger.com/anm

68. Hayashi T et al. "Ellagitannins from Lagerstroemia speciosa asactivators of glucose transport in fat cells." Planta Med. 68,2:173-5, 2002.

69. Park MY, Lee KS, Sung MK. "Effects of dietary mulberry, Korean redginseng and banaba on glucose homeostastis in relation to PPAR-alpha, PPAR-gammaand LPL mRNA expressions." Life Sci. June 22, 2005. [epub ahead ofprint] www.sciencedirect.com/science/journal/00243205

70. Liu F et al. "An extract of Lagerstroemia speciosa L. hasinsulin-like glucose uptake-stimulatory and adipocyte differentiation-inhibitoryactivities in 3T3-L1 cells." J Nutr. 131, 9:2242-7, 2001. www.nutrition.org

71. Suzuki Y et al. "Antiobesity activity of extracts from Lagerstroemiaspeciosa L. leaves on female KK-Ay mice." J Nutr Sci Vitaminol (Tokyo).45, 6:791-5, 1999. http://eishoku.bcasj.or.jp/journal-e.html

72. Pusztai A et al. "Lipid accumulation in obese Zucker rats is reducedby inclusion of raw kidney bean (Phaseolus vulgaris) in the diet." Br JNutr. 79, 2:213-21, 1998. www.cabi-publishing.org/journals/bjn

73. Tormo MA et al. "Hypoglycaemic and anorexigenic activities of analpha-amylase inhibitor from white kidney beans (Phaseolus vulgaris) in Wistarrats." Br J Nutr. 92, 5:785-90, 2004. www.cabi-publishing.org/journals/bjn

74. Udani J, Hardy M, Madsen DC. "Blocking carbohydrate absorption andweight loss: a clinical trial using Phase 2 brand proprietary fractionated whitebean extract." Altern Med Rev. 9, 1:63-9, 2004. www.thorne.com/altmedrev

75. Zahorska-Markiewicz B et al. "[Effect of chitosan in complexmanagement of obesity.]" Pol Merkuriusz Lek. 13, 74:129-32, 2002.

76. Mhurchu CN et al. "The effect of the dietary supplement, chitosan,on body weight: a randomized controlled trial in 250 overweight and obeseadults." Int J Obes Relat Metab Disord. 28, 9:1149-56, 2004. http://www-us.ebsco.com/online/OnlineTitles.asp

77. Ni MC et al. "Chitosan for overweight or obesity." CochraneDatabase Syst Rev. 3:CD003892, 2005. www.cochrane.org

78. "Pilot clinical study of NeOpuntia<\#168> on fatbinding." Presented at Annual Conference on Weight Loss Ingredients Paris.SFA May 2004.

79. Smeets-Peeters MJE, Minekus M. "Fat binding capacity of NeOpuntiaduring passage through a dynamic gastrointestinal model." Presented atVitaFoods May 2001.